Does chemotherapy modify the immune surveillance of hematological malignancies? - Wikidata - wikimedia - TriplyDB

Does chemotherapy modify the immune surveillance of hematological malignancies?

Does chemotherapy modify the immune surveillance of hematological malignancies?

http://www.wikidata.org/entity/Q34223517

about

Update on the challenges and recent advances in cancer immunotherapy Chronic myeloid leukemia patients in prolonged remission following interferon-α monotherapy have distinct cytokine and oligoclonal lymphocyte profile In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors.Adult Acute Myeloid Leukemia Long-term Survivors.Implication of early lymphocyte recovery after allogeneic hematopoietic stem cell transplantation in children with leukemia Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies.Dendritic cell-based immunotherapy for myeloid leukemias.Immunotherapy prospects for acute myeloid leukaemia.Clinical evaluation of cellular immunotherapy in acute myeloid leukaemia.Biological therapy and the immune system in patients with chronic myeloid leukemia.Hematological malignancies escape from NK cell innate immune surveillance: mechanisms and therapeutic implications.Cancer-immune equilibrium: questions unanswered Bone marrow T-cell percentage: A novel prognostic indicator in acute myeloid leukemia.Interferon-induced programmed death-ligand 1 (PD-L1/B7-H1) expression increases on human acute myeloid leukemia blast cells during treatment.A mathematical model of tumour growth with Beddington-DeAngelis functional response: a case of cancer without disease.Absolute lymphocyte count at day 28 independently predicts event-free and overall survival in adults with newly diagnosed acute lymphoblastic leukemia.Absolute lymphocyte counts at end of induction correlate with distinct immune cell compartments in pediatric B cell precursor acute lymphoblastic leukemia.Pretreatment serum level of 15-kDa granulysin might have a prognostic value in patients with diffuse large B cell lymphoma.Cancer; an induced disease of twentieth century! Induction of tolerance, increased entropy and 'Dark Energy': loss of biorhythms (Anabolism v. Catabolism).Is Absolute Lymphocyte Count Just Another Prognostic Factor in Cancer?

P2860

Q27014693-035AE993-8EEE-4343-955A-56552E440B78 Q28476476-663D1CE0-0E29-403E-84B1-5121841026B0 Q34154994-19907D00-5595-4D07-90BA-2F2283156353 Q34202366-9FD961A3-CDF6-4A98-8202-4735B22EAFF9 Q36463940-D4946215-6411-401B-BA83-5D3E1F2C297A Q37222203-74245789-9F12-4935-84A1-AFC330D09AE8 Q37420778-0FBA9FEE-9D97-4E14-9263-ACE98E6B6012 Q37763280-14FDFE00-E234-43FA-95CF-BB1880634DBF Q37868974-6134F59F-C3A4-4F2F-B9CC-6526CA78D0EF Q38015742-A0EE31C9-3FD9-4450-B7C7-603AE9694C15 Q38035301-706F9B9A-6D1F-4501-854A-2995F7215065 Q38366247-253AF7FB-649E-4766-A742-345D6F36F401 Q40445337-B8A73E73-6BF1-46E3-A035-93BD03BE10FA Q44891305-4F81012E-1E12-49C3-8788-DAC1584F37F6 Q47565476-6CC4966F-DBB5-45D2-BC30-6F9C93B23A57 Q47581845-CEF53EB2-DDB6-43B4-A7CF-DBE11D90A042 Q48156506-82ADA784-68EF-4216-964B-E3BF257E9AE1 Q53250468-27EA4F3B-457E-4541-A7EC-D212B4171301 Q55709806-DDB30181-C139-40E9-AEA8-A07D1A165622 Q58650169-D36AD674-6F66-40A8-A386-1CB69F8AF679

P2860

Does chemotherapy modify the immune surveillance of hematological malignancies?

http://www.wikidata.org/entity/Q34223517

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Does chemotherapy modify the immune surveillance of hematological malignancies?

@ast

Does chemotherapy modify the immune surveillance of hematological malignancies?

@en

Does chemotherapy modify the immune surveillance of hematological malignancies?

@nl

type

label

Does chemotherapy modify the immune surveillance of hematological malignancies?

@ast

Does chemotherapy modify the immune surveillance of hematological malignancies?

@en

Does chemotherapy modify the immune surveillance of hematological malignancies?

@nl

prefLabel

Does chemotherapy modify the immune surveillance of hematological malignancies?

@ast

Does chemotherapy modify the immune surveillance of hematological malignancies?

@en

Does chemotherapy modify the immune surveillance of hematological malignancies?

@nl

P1433

Q34223517-70EA7CDF-5550-475E-AE22-F17F96A78D40

P1476

Q34223517-0C015F16-D6F8-40BC-B026-8C98D6FA834B

P2093

Q34223517-5DB7EA0F-404C-4D00-BD7A-3DE204BEDF99

Q34223517-A71A6006-2F47-4E6E-9016-760B64E3FC22

P2860

Q34223517-014C7199-FFF8-46ED-A039-FACF93D7C924

Q34223517-02D038D9-9C1D-43CF-B3A1-40AED9ED3B03

Q34223517-0A473DE9-929D-45D7-8A03-6E0570C6F5A5

Q34223517-0B3FDFE6-F7DA-4E57-A5B3-03A903D83E70

Q34223517-16B654CF-879D-4FD1-A6DC-EC0B06A30817

Q34223517-206CECFD-81D9-4463-A88A-BA20AE8E9606

Q34223517-24CB22AA-0C84-4F50-9226-60566A26BA90

Q34223517-2C1CDCE2-B8BE-4A33-ACAD-076E9B5A4113

Q34223517-2D0D0697-BFAE-474C-9BE3-3BE61034192E

Q34223517-37055C9C-FF5B-4BB2-812B-6FBDD44FE4A8

P2888

Q34223517-EF040E3A-ECEE-4469-A360-FDE4DA6D0E61

P304

Q34223517-A3E1C720-87ED-467A-BE95-996CA5D23557

P31

Q34223517-A398C68C-66C5-4AE8-AC24-ED13284FEA9E

P356

Q34223517-017BA72D-9CC0-460F-877F-B5A230AC1501

P433

Q34223517-3E3C90F4-9805-4FE2-9CF8-4C3C49232487

P478

Q34223517-C487B205-2B10-49B4-A354-75D98D8CD53D

P577

Q34223517-6AAA9542-7D53-46C5-AE0D-5EBCB9433280

P5875

Q34223517-E8A402C2-4937-430E-B80A-1E6D6606B064

P6179

Q34223517-E4D67602-D2D4-493F-8E03-171A525C5C21

P698

Q34223517-4154072F-AAE9-47F1-8333-A28D4582381C

P921

Q34223517-0AF263FB-EC26-4882-BCA6-E40953162726

P932

Q34223517-CB043910-1428-4AA6-B6AA-2B4A5A3BCDC1

P356

P1433

P1476

Does chemotherapy modify the immune surveillance of hematological malignancies?

@en

P2093

A J Barrett

http://www.w3.org/2001/XMLSchema#string

B N Savani

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

The three Es of cancer immunoediting

Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes.

Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population.

Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.

Immune surveillance of tumors.

Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect.

Autologous graft-versus-host disease: a novel approach for antitumor immunotherapy.

P2888

P304

53-58

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LEU.2008.273

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23294906

http://www.w3.org/2001/XMLSchema#string

P6179

1035957409

http://www.w3.org/2001/XMLSchema#string

P698

18830260

http://www.w3.org/2001/XMLSchema#string

P921

P932

4170943

http://www.w3.org/2001/XMLSchema#string